Pharmakaisercentre
Board
2 directors, no change since 2023Director (not named in the articles)
since 01-12-2014
earlier manager, until 28-12-2023
listed in the 2025 annual accounts, filed on 30-08-2026
Manager (not named in the articles)
since 01-12-2014
term without a fixed end
also on the board of 1 other company
listed in the 2025 annual accounts, filed on 30-08-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “Chaque administrateur représente la société à l'égard des tiers et en justice, soit en demandant, soit en défendant.”deed of 28-12-2023
Mandates through the years
2 names, the dashed line is todayDirector (not named in the articles)
Manager (not named in the articles)
BoardEarliermandate already running before its first mention
Mandates as a list
-
- Director (not named in the articles), from 01-12-2014 to date
- Manager, until 28-12-2023
-
- Manager (not named in the articles), from 01-12-2014 to date
Control
Founder
This company
Pharmakaisercentre
Equity €216,481
Profit €50,800 in 2025
Capital
- Contribution
- €12,400
- Shares
- 186
- Contribution per share
- €66.67
- Equity per share
- €1,164 in 2025
- Source
- 2025 annual accounts
Articles of association
deed of 28-12-2023 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- Moitié cédant moitié acquéreurs proportionnellement nombre actions, cessions entre vifs onéreuses ou gratuites,volontaires ou forcées dont exclusion et retrait,…
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Fourth Saturday of May at 20:00
Shareholders
At incorporation
deed of 03-12-2014 ↗
- 186 shares (100%) · €18,600
Capital transactions
Capital over time
- 28-12-2023 Converted to unavailable equity
- 03-12-2014 Incorporation · €18,600 · 186 shares